Literature DB >> 27443047

Over-Prescribed Medications, Under-Appreciated Risks: A Review of the Cognitive Effects of Anticholinergic Medications in Older Adults.

Daniel M I Britt, Gregory S Day.   

Abstract

Anticholinergic medications are associated with adverse cognitive effects in cognitively normal and impaired individuals, with a greater magnitude of effect observed in individuals with preexisting cognitive impairment due to Alzheimer disease.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27443047      PMCID： PMC5125613     

Source DB:  PubMed          Journal:  Mo Med        ISSN： 0026-6620


  78 in total

1.  State-specific projections through 2025 of Alzheimer disease prevalence.

Authors:  L E Hebert; P A Scherr; J L Bienias; D A Bennett; D A Evans
Journal:  Neurology       Date:  2004-05-11       Impact factor: 9.910

Review 2.  Drug-induced cognition disorders in the elderly: incidence, prevention and management.

Authors:  S L Gray; K V Lai; E B Larson
Journal:  Drug Saf       Date:  1999-08       Impact factor: 5.606

3.  Unrecognized preclinical Alzheimer disease confounds rs-fcMRI studies of normal aging.

Authors:  Matthew R Brier; Jewell B Thomas; Abraham Z Snyder; Liang Wang; Anne M Fagan; Tammie Benzinger; John C Morris; Beau M Ances
Journal:  Neurology       Date:  2014-09-26       Impact factor: 9.910

4.  Place navigation in rats is impaired by lesions of medial septum and diagonal band but not nucleus basalis magnocellularis.

Authors:  J J Hagan; J D Salamone; J Simpson; S D Iversen; R G Morris
Journal:  Behav Brain Res       Date:  1988-01       Impact factor: 3.332

Review 5.  A review on cholinesterase inhibitors for Alzheimer's disease.

Authors:  Preet Anand; Baldev Singh
Journal:  Arch Pharm Res       Date:  2013-02-24       Impact factor: 4.946

Review 6.  Cerebrospinal fluid biomarkers of Alzheimer's disease.

Authors:  Anne M Fagan; David M Holtzman
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

7.  The impact of anticholinergic burden in Alzheimer's dementia-the LASER-AD study.

Authors:  Chris Fox; Gill Livingston; Ian D Maidment; Simon Coulton; David G Smithard; Malaz Boustani; Cornelius Katona
Journal:  Age Ageing       Date:  2011-09-18       Impact factor: 10.668

8.  Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride.

Authors:  I R Katz; L P Sands; W Bilker; S DiFilippo; A Boyce; K D'Angelo
Journal:  J Am Geriatr Soc       Date:  1998-01       Impact factor: 5.562

9.  A drug burden index to define the functional burden of medications in older people.

Authors:  Sarah N Hilmer; Donald E Mager; Eleanor M Simonsick; Ying Cao; Shari M Ling; B Gwen Windham; Tamara B Harris; Joseph T Hanlon; Susan M Rubin; Ronald I Shorr; Douglas C Bauer; Darrell R Abernethy
Journal:  Arch Intern Med       Date:  2007-04-23

10.  Estrogen treatment effects on anticholinergic-induced cognitive dysfunction in normal postmenopausal women.

Authors:  Julie Dumas; Catherine Hancur-Bucci; Magdalena Naylor; Cynthia Sites; Paul Newhouse
Journal:  Neuropsychopharmacology       Date:  2006-02-15       Impact factor: 7.853
View more
  5 in total

1.  Association of Parkinsonism or Parkinson Disease with Polypharmacy in the Year Preceding Diagnosis: A Nested Case-Control Study in South Korea.

Authors:  Hae-Young Park; Ji-Won Park; Hyun Soon Sohn; Jin-Won Kwon
Journal:  Drug Saf       Date:  2017-11       Impact factor: 5.606

Review 2.  Anticholinergics for Overactive Bladder in Frail and Medically Complex Older People: The Case For.

Authors:  Adrian Wagg
Journal:  Drugs Aging       Date:  2018-09       Impact factor: 3.923

Review 3.  Rapidly Progressive Dementia.

Authors:  Gregory S Day
Journal:  Continuum (Minneap Minn)       Date:  2022-06-01

4.  The cognitive effects of anticholinergic drugs on apolipoprotein ε4 carriers and noncarriers in the Wisconsin Registry for Alzheimer's Prevention study.

Authors:  Brian G Collin; Dheeraj Raju; Steven Katsikas
Journal:  Neuropsychology       Date:  2021-02       Impact factor: 3.295

5.  Medications causing potential cognitive impairment are common in nursing home dementia units - A cross-sectional study.

Authors:  Jenny Hansen Kristensson; Iris Zahirovic; Elisabet Londos; Sara Modig
Journal:  Explor Res Clin Soc Pharm       Date:  2021-08-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.